BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 34432221)

  • 21. m
    Li W; Liu J; Ma Z; Zhai X; Cheng B; Zhao H
    Dis Markers; 2021; 2021():8859590. PubMed ID: 34234878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expressions of m6A RNA methylation regulators and their clinical predictive value in cervical squamous cell carcinoma and endometrial adenocarcinoma.
    Wu H; Dong H; Fu Y; Tang Y; Dai M; Chen Y; Wang G; Wu Y
    Clin Exp Pharmacol Physiol; 2021 Feb; 48(2):270-278. PubMed ID: 33006785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. m6A RNA methylation regulators play an important role in the prognosis of patients with testicular germ cell tumor.
    Cong R; Ji C; Zhang J; Zhang Q; Zhou X; Yao L; Luan J; Meng X; Song N
    Transl Androl Urol; 2021 Feb; 10(2):662-679. PubMed ID: 33718069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of m6A RNA methylation regulators on endometrial cancer.
    Zhang Y; Yang Y
    J Clin Lab Anal; 2021 Sep; 35(9):e23942. PubMed ID: 34347888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multi-omics analysis of N6-methyladenosine reader IGF2BP3 as a promising biomarker in pan-cancer.
    Chen P; Xu J; Cui Z; Wu S; Xie T; Zhang X
    Front Immunol; 2023; 14():1071675. PubMed ID: 36761737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple m
    Qu N; Qin S; Zhang X; Bo X; Liu Z; Tan C; Wen G; Jiang H
    BMC Cancer; 2020 Feb; 20(1):165. PubMed ID: 32111180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N6-Methyladenosine RNA Methylation Regulator-Related Alternative Splicing (AS) Gene Signature Predicts Non-Small Cell Lung Cancer Prognosis.
    Zhao Z; Cai Q; Zhang P; He B; Peng X; Tu G; Peng W; Wang L; Yu F; Wang X
    Front Mol Biosci; 2021; 8():657087. PubMed ID: 34179079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contributions and Prognostic Values of N6-Methyladenosine RNA Methylation Regulators in Hepatocellular Carcinoma.
    Qi LW; Jia JH; Jiang CH; Hu JM
    Front Genet; 2020; 11():614566. PubMed ID: 33519919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of m6A methyltransferase-related genes predicts prognosis and immune infiltrates in head and neck squamous cell carcinoma.
    Zhang Y; Li L; Ye Z; Zhang L; Yao N; Gai L
    Ann Transl Med; 2021 Oct; 9(20):1554. PubMed ID: 34790760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of N6-Methyladenosine Regulators on Progression and Prognosis of Triple-Negative Breast Cancer.
    Wang S; Zou X; Chen Y; Cho WC; Zhou X
    Front Genet; 2020; 11():580036. PubMed ID: 33584787
    [No Abstract]   [Full Text] [Related]  

  • 31. Identification of an m6A RNA Methylation Regulator Risk Score Model for Prediction of Clinical Prognosis in Astrocytoma.
    Guo F; Deng T; Shi L; Wu P; Yan J; Ling G; Chen H; Huang Q; Mu J; Mo L
    Comput Math Methods Med; 2022; 2022():7168929. PubMed ID: 35047056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N
    Zheng X; Li S; Yu J; Dai C; Yan S; Chen G; Sun C
    Transl Cancer Res; 2023 Apr; 12(4):992-1005. PubMed ID: 37180667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic Impact of
    Guo W; Huai Q; Wan H; Guo L; Song P; Gao S; He J
    DNA Cell Biol; 2021 Feb; 40(2):316-331. PubMed ID: 33493403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RNA N1-methyladenosine regulator-mediated methylation modification patterns and heterogeneous signatures in glioma.
    Mao M; Chu Q; Lou Y; Lv P; Wang LJ
    Front Immunol; 2022; 13():948630. PubMed ID: 35936006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The RNA N
    Jin L; Chen C; Yao J; Yu Z; Bu L
    Clin Exp Pharmacol Physiol; 2022 Mar; 49(3):329-340. PubMed ID: 34717005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic risk signature based on the expression of three m6A RNA methylation regulatory genes in kidney renal papillary cell carcinoma.
    Sun Z; Jing C; Xiao C; Li T; Wang Y
    Aging (Albany NY); 2020 Nov; 12(21):22078-22094. PubMed ID: 33177247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. m
    Chen L; Hu B; Song X; Wang L; Ju M; Li Z; Zhou C; Zhang M; Wei Q; Guan Q; Jiang L; Chen T; Wei M; Zhao L
    Front Oncol; 2021; 11():598017. PubMed ID: 33796449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Construction and validation of a m6A RNA methylation and ferroptosis-related prognostic model for pancreatic cancer by integrated bioinformatics analysis.
    Wu T; Qian TY; Lin RJ; Jin DD; Xu XB; Huang MX; Ji J; Jiang F; Pan LL; Luo L; Ji YF; Chen QL; Xiao MB
    J Gastrointest Oncol; 2022 Oct; 13(5):2553-2564. PubMed ID: 36388690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic Value of an m6A RNA Methylation Regulator-Based Signature in Patients with Hepatocellular Carcinoma.
    Wu X; Zhang X; Tao L; Dai X; Chen P
    Biomed Res Int; 2020; 2020():2053902. PubMed ID: 32733931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive analysis of m6A regulators prognostic value in prostate cancer.
    Ji G; Huang C; He S; Gong Y; Song G; Li X; Zhou L
    Aging (Albany NY); 2020 Jul; 12(14):14863-14884. PubMed ID: 32710725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.